Royal London Asset Management Ltd. Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Royal London Asset Management Ltd. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 346,451 shares of the medical equipment provider’s stock after selling 1,970 shares during the period. Royal London Asset Management Ltd. owned approximately 0.10% of Intuitive Surgical worth $180,834,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $492.06 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a 50-day simple moving average of $564.39 and a 200-day simple moving average of $531.62. The company has a market cap of $175.26 billion, a PE ratio of 76.76, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.